4//SEC Filing
Holveck David 4
Accession 0001209191-12-012982
CIK 0001100962other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 5:22 PM ET
Size
14.7 KB
Accession
0001209191-12-012982
Insider Transaction Report
Form 4
Holveck David
DirectorPresident & CEO
Transactions
- Award
2010 Stock Incentive Plan Performance Shares
2012-02-22+52,834→ 104,747 total - Award
2010 Stock Incentive Plan Stock Options
2012-02-22+173,940→ 173,940 totalExercise: $34.70Exp: 2022-02-22→ Common Stock (173,940 underlying) - Award
2010 Stock Incentive Plan Restricted Stock Units (RSU)
2012-02-22+52,834→ 91,768 total
Footnotes (7)
- [F1]Upon each vesting date, each vested restricted stock unit automatically converts into one (1) share of Endo Pharmaceuticals Holdings Inc. common stock. These restricted stock units (RSUs) are generally exercisable 25% per year on each of February 22, 2013, February 22, 2014, February 22, 2015 and February 22, 2016. Upon vesting, we consider the underlying RSUs to be expired. Pursuant to the Endo Pharmaceuticals Executive Deferred Compensation Plan, on November 8, 2009, Mr. Holveck elected to defer receipt of all of these RSUs until February 1, 2016.
- [F2]Pursuant to the Endo Pharmaceuticals Executive Deferred Compensation Plan, on November 8, 2009, Mr. Holveck elected to defer receipt of all of these RSUs until February 1, 2016.
- [F3]These securities were granted to Mr. Holveck in consideration of his services as the President & Chief Executive Officer of Endo Pharmaceuticals Holdings Inc.
- [F4]The performance shares vest upon the Company achieving certain financial targets.
- [F5]Represents target quantity of shares issuable. The exact number of shares issuable will be determined on achievement of certain company performance targets over a cumulative 3-year period, as determined by the Compensation Committee of the Board of Directors of Endo Pharmaceuticals Holdings Inc. The executive can earn between 0% and 200% of the target shares.
- [F6]Representing the right to buy shares of common stock, par value $0.01 per share, of Endo Pharmaceuticals Holdings Inc.
- [F7]These stock options are generally exercisable 25% per year on each of February 22, 2013, February 22, 2014, February 22, 2015 and February 22, 2016.
Issuer
ENDO PHARMACEUTICALS HOLDINGS INC
CIK 0001100962
Entity typeother
Related Parties
1- filerCIK 0001429993
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 5:22 PM ET
- Size
- 14.7 KB